Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,797 | 56,902 | 169,402 | 14,626 | 25,900 |
| Marketable Securities | 211,572 | 217,324 | 133,581 | 121,962 | 129,083 |
| Receivables | 525 | 305 | 489 | 890 | 12 |
| TOTAL | $255,597 | $276,819 | $305,189 | $139,946 | $156,430 |
| Non-Current Assets | |||||
| PPE Net | 10,601 | 10,216 | 9,973 | 8,814 | 7,338 |
| Intangibles | 31,278 | 31,532 | 31,785 | 32,038 | 32,291 |
| Other Non-Current Assets | 116 | 132 | 148 | 157 | 174 |
| TOTAL | $41,995 | $41,880 | $41,906 | $41,009 | $39,803 |
| Total Assets | $297,592 | $318,699 | $347,095 | $180,955 | $196,233 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,118 | 1,127 | N/A | 1,006 | N/A |
| Accounts payable and accrued liabilities | 1,187 | 3,414 | 2,243 | 1,982 | 2,069 |
| Accrued Expenses | 17,897 | 14,966 | 17,179 | 13,807 | 9,904 |
| Other current liabilities | N/A | N/A | 928 | N/A | 530 |
| TOTAL | $21,202 | $19,507 | $20,350 | $16,795 | $12,503 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,075 | 7,346 | 6,950 | 7,415 | 6,636 |
| TOTAL | $11,075 | $7,346 | $6,950 | $7,415 | $6,636 |
| Total Liabilities | $32,277 | $26,853 | $27,300 | $24,210 | $19,139 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,963 | 5,960 | 5,953 | 5,410 | 5,402 |
| Common Shares | 89 | 89 | 89 | 81 | 81 |
| Retained earnings | -403,856 | -375,582 | -345,679 | -323,617 | -300,477 |
| Other shareholders' equity | 2,748 | 2,670 | 2,668 | 2,686 | 2,548 |
| TOTAL | $265,315 | $291,846 | $319,795 | $156,745 | $177,094 |
| Total Liabilities And Equity | $297,592 | $318,699 | $347,095 | $180,955 | $196,233 |